Patent Assignment
Reel/Frame 063979/0709
Security Interest
Recorded: 2023-06-16
Pages: 11
Assignor
MOLECULAR TEMPLATES, INC.
Executed: 2023-06-16
Assignee
ANKURA TRUST COMPANY, LLC, AS COLLATERAL TRUSTEE
140 SHERMAN STREET, FOURTH FLOOR, FAIRFIELD, CONNECTICUT, 06824
Covered Properties
(33)
Method for Determining Susceptibility of Tumor to Treatment with Anti-Neoplastic Agent
Treatment of Cancer with Glufosfamide in Patients Not Receiving Insulin Therapy
Hypoxia Activated Drugs of Nitrogen Mustard Alkylators
Camptothecin Derivatives
Anti-Cancer Therapies
CD20-Binding Proteins Comprising Shiga Toxin a Subunit Effector Regions for Inducing Cellular Internalization and Methods Using Same
CD20-Binding Immunotoxins for Inducing Cellular Internalization and Methods Using Same
Methods of Screening, Selecting, and Identifying Cytotoxic Recombinant Polypeptides Based on an Interim Diminution of Ribotoxicity
Multivalent CD20-Binding Molecule Comprising Shiga Toxin a Subunit Effector Polypeptides and Enriched Compositions Thereof
Cell-Targeting Molecules Comprising Protease-Cleavage Resistant, Shiga Toxin A Subunit Effector Polypeptides and Carboxy-Terminal Moieties
Multivalent CD20-Binding Molecules Comprising Shiga Toxin a Subunit Effector Regions and Enriched Compositions Thereof
Multivalent CD20-Binding Molecules Comprising Shiga Toxin a Subunit Effector Regions and Enriched Compositions Thereof
CD38-Binding Proteins Comprising De-Immunized Shiga Toxin a Subunit Effectors
Pd-L1-Binding Molecules Comprising Shiga Toxin a Subunit Scaffolds
Pd-L1-Binding Molecules Comprising Shiga Toxin a Subunit Scaffolds
Cell-Targeting Molecules Comprising Protease-Cleavage Resistant, Shiga Toxin a Subunit Effector Polypeptides and Carboxy-Terminal Moieties
Application:
17/030,657 →
Publication:
US 2021/0017512
HER2-Targeting Molecules Comprising De-Immunized, Shiga Toxin a Subunit Scaffolds
Cell-Targeting Molecules Comprising De-Immunized, Shiga Toxin a Subunit Effectors and CD8+ T-Cell Epitopes
Mhc Class I Epitope Delivering Polypeptides
De-Immunized, Shiga Toxin a Subunit Scaffolds and Cell-Targeting Molecules Comprising the Same
Shiga Toxin a Subunit Effector Polypeptides, Shiga Toxin Effector Scaffolds, and Cell-Targeting Molecules for Site-Specific Conjugation
Patent:
11,389,542 →
Application:
17/314,563 →
De-Immunized Shiga Toxin a Subunit Effector Polypeptides for Applications in Mammals
Cell-Targeting Molecules Comprising Shiga Toxin a Subunit Effectors and CD8+ T-Cell Epitopes
Application:
17/459,133 →
Publication:
US 2022/0401568
Shiga Toxin a Subunit Effector Polypeptides, Shiga Toxin Effector Scaffolds, and Cell-Targeting Molecules for Site-Specific Conjugation
Clinical Methods for Use of a Pd-L1-Binding Molecule Comprising a Shiga Toxin Effector
Pd-L1 Binding Proteins Comprising Shiga Toxin a Subunit Scaffolds and CD8+ T Cell Antigens
Application:
17/697,564 →
Publication:
US 2022/0306700
Mhc Class I Epitope Delivering Polypeptides
Proteins Comprising Binding Regions, Shiga Toxin a Subunit Effector Regions, and Carboxy-Terminal, Endoplasmic Reticulum Localization Signal Motifs
Application:
17/734,881 →
Publication:
US 2022/0267384
De-Immunized, Shiga Toxin a Subunit Scaffolds and Cell-Targeting Molecules Comprising the Same
Application:
17/746,106 →
Publication:
US 2022/0281926
Cell-Targeting Molecules Comprising De-Immunized, Shiga Toxin a Subunit Effectors and CD8+ T-Cell Epitopes
Application:
17/852,669 →
Publication:
US 2022/0354938
Clinical Methods for Use of HER2 Binding Molecules
Application:
18/006,216 →
Publication:
US 2023/0295342
HER2-Targeting Molecules Comprising De-Immunized, Shiga Toxin a Subunit Scaffolds
Application:
18/170,158 →
Publication:
US 2023/0331785
Ctla-4 Binding Molecules Comprising Shiga Toxin a Subunit Scaffolds and Uses Thereof
Application:
18/180,785 →
Publication:
US 2023/0357406
Related Assignments
(20)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 8, 2010
From: HANDISIDES, DAMIAN; KROLL, STEWART; DUAN, JIAN-XIN; SELICK, HAROLD E.
To: THRESHOLD PHARMACEUTICALS, INC.
Reel/Frame 023753/0654 →
Assignment of Assignor's Interest
Mar 28, 2011
From: LEWIS, JASON; MATTEUCCI, MARK; CHEN, TAO; JIAO, HAILONG
To: THRESHOLD PHARMACEUTICALS
Reel/Frame 026034/0378 →
Assignment of Assignor's Interest
Mar 2, 2012
From: CAI, XIAOHONG; DUAN, JIAN-XIN; MATTEUCCI, MARK; CAO, YEYU
To: THRESHOLD PHARMACEUTICALS, INC.
Reel/Frame 027800/0432 →
Assignment of Assignor's Interest
Oct 2, 2016
From: POMA, ERIC; WILLERT, ERIN; KIM, JASON; HIGGINS, JACK
To: MOLECULAR TEMPLATES, INC.
Reel/Frame 039917/0015 →
Assignment of Assignor's Interest
Oct 25, 2016
From: POMA, ERIC; WILLERT, ERIN; KIM, JASON; HIGGINS, JACK
To: MOLECULAR TEMPLATES, INC.
Reel/Frame 040118/0025 →
Assignment of Assignor's Interest
Apr 12, 2017
From: POMA, ERIC; WILLERT, ERIN; HIGGINS, JACK; KIM, JASON
To: MOLECULAR TEMPLATES, INC.
Reel/Frame 041982/0283 →
Assignment of Assignor's Interest
Apr 12, 2017
From: POMA, ERIC; WILLERT, ERIN; KIM, JASON; HIGGINS, JACK
To: MOLECULAR TEMPLATES, INC.
Reel/Frame 041982/0073 →
Security Agreement
Feb 28, 2018
From: MOLECULAR TEMPLATES OPCO, INC.; MOLECULAR TEMPLATES, INC.
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 045466/0472 →
Change of Name and Address
Oct 12, 2018
From: THRESHOLD PHARMACEUTICALS, INC.
To: MOLECULAR TEMPLATES, INC.
Reel/Frame 048404/0347 →
Assignment of Assignor's Interest
Apr 26, 2019
From: POMA, ERIC; WILLERT, ERIN; KIM, JASON; HIGGINS, JACK
To: MOLECULAR TEMPLATES, INC.
Reel/Frame 049011/0599 →
Corrective Assignment to Correct the Receiving Party Address Previously Recorded at Reel: 49011 Frame: 599. Assignor(S) Hereby Confirms the Assignment.
Jun 27, 2019
From: POMA, ERIC; WILLERT, ERIN; KIM, JASON; HIGGINS, JACK
To: MOLECULAR TEMPLATES, INC.
Reel/Frame 049616/0266 →
Assignment of Assignor's Interest
Nov 15, 2019
From: POMA, ERIC; WILLERT, ERIN; KIM, JASON; HIGGINS, JACK
To: MOLECULAR TEMPLATES, INC.
Reel/Frame 051024/0063 →
Change of Name
May 7, 2020
From: THRESHOLD PHARMACEUTICALS, INC.
To: MOLECULAR TEMPLATES, INC.
Reel/Frame 052607/0818 →
Release of Security Interest
May 22, 2020
From: PERCEPTIVE CREDIT HOLDINGS II, LP
To: MOLECULAR TEMPLATES OPCO, INC.
Reel/Frame 052733/0890 →
Assignment of Assignor's Interest
May 11, 2021
From: POMA, ERIC; WILLERT, ERIN; HIGGINS, JACK; KIM, JASON
To: MOLECULAR TEMPLATES, INC.
Reel/Frame 056204/0844 →
Assignment of Assignor's Interest
Aug 24, 2021
From: POMA, ERIC; RAMOS, HILARIO; WILLERT, ERIN; SHIMKETS, RICHARD
To: MOLECULAR TEMPLATES, INC.
Reel/Frame 057270/0704 →
Assignment of Assignor's Interest
Nov 8, 2021
From: POMA, ERIC; WILLERT, ERIN; HIGGINS, JACK
To: MOLECULAR TEMPLATES, INC.
Reel/Frame 058042/0663 →
Assignment of Assignor's Interest
Nov 8, 2021
From: POMA, ERIC; RAMOS, HILARIO; WILLERT, ERIN; SHIMKETS, RICHARD
To: MOLECULAR TEMPLATES, INC.
Reel/Frame 058042/0698 →
Assignment of Assignor's Interest
Aug 26, 2022
From: POMA, ERIC; WILLERT, ERIN
To: MOLECULAR TEMPLATES, INC.
Reel/Frame 060911/0853 →
Assignment of Assignor's Interest
Aug 26, 2022
From: CHATTOPADHYAY, NIBEDITA
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 060911/0900 →